Revvity Inc (RVTY) Q4 2025 Earnings Call Highlights: Surpassing EPS Guidance and Strategic ... [Yahoo! Finance]
Revvity, Inc. (RVTY)
Company Research
Source: Yahoo! Finance
Organic Growth: 3% for the year, within original guidance range. Diagnostic Segment Organic Growth: 7% in Q4. Life Sciences Segment Revenue: $382 million in Q4, flat organic growth. Adjusted Operating Margin: 29.7% in Q4. Share Repurchases: Over $800 million in 2025, reducing share count by 8.5 million shares. Revenue: $772 million in Q4, 4% organic growth. Free Cash Flow: $162 million in Q4, 84% conversion of adjusted net income. 2026 Revenue Outlook: $2.96 billion to $2.99 billion. 2026 Adjusted EPS Guidance: $5.35 to $5.45. 2026 Organic Growth Outlook: 2% to 3%. 2026 Adjusted Operating Margin Target: Warning! GuruFocus has detected 7 Warning Signs with RVTY. Is RVTY fairly valued? Test your thesis with our free DCF calculator. Release Date: February 02, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript Revvity Inc ( NYSE:RVTY ) exceeded its adjusted EPS guidance for 2025, achieving $5.06, surpassi
Show less
Read more
Impact Snapshot
Event Time:
RVTY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RVTY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RVTY alerts
High impacting Revvity, Inc. news events
Weekly update
A roundup of the hottest topics
RVTY
News
- Revvity (RVTY) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Emerald Growth Equity Strategy Sold Revvity (RVTY) in Q4 [Yahoo! Finance]Yahoo! Finance
- Volition Announces First Ever Automated Nu.Q® Vet Cancer Test with Fujifilm Vet Systems [Yahoo! Finance]Yahoo! Finance
- Bretton Fund Exited Revvity (RVTY) in 2025 [Yahoo! Finance]Yahoo! Finance
- Revvity (RVTY) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d+)" to "hold (c-)".MarketBeat
RVTY
Earnings
- 2/2/26 - Beat
RVTY
Sec Filings
- 3/18/26 - Form 4
- 3/16/26 - Form ARS
- 3/16/26 - Form DEFA14A
- RVTY's page on the SEC website